The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer
Cancer Reports · 2025
DOI: 10.1002/cnr2.70167 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Reports, 2025. Verfasst von Ming Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: HaploX Biotechnology, Shenzhen, China. Hauptthemen laut MEDLINE: Neoplasm, Residual, Circulating Tumor DNA, Colorectal Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Province Key Areas R&D Plan Project Fund, Shenzhen Science and Technology Innovation Committee Technical Research Project.
Abstract (Originalsprache)
Background
Colorectal cancer (CRC) remains a significant health concern in the world. The existing standard of care guidelines for CRC surveillance fall short of effectively and timely detecting recurrence or metastasis. Recent Findings In recent years, circulating tumor DNA (ctDNA) has emerged as a promising material for minimal residual disease (MRD) detection. In this article, we provide an exhaustive review of the methods utilized for MRD detection via ctDNA, present evidence supporting the potential of ctDNA MRD as a valuable biomarker in clinical applications, and engage in a discussion regarding ongoing ctDNA MRD‐based clinical trials in CRC. Finally, we offer insights into future prospects of ctDNA‐based MRD methodological advancements and clinical research.
Conclusion
It is foreseeable that more sensitive, flexible, and economical MRD detection methods will emerge with the deeper research on cell‐free DNA (cfDNA) genomics, fragmentomics, methylomes, and nucleosome imprinting. At the same time, MRD‐guided intervention studies will evolve for revolutionizing the treatment paradigm of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HaploX Biotechnology, Shenzhen, China.
- Faculty of Data Science, City University of Macau, Macau, China.
ORCID-Profile: Ming Liu
Förderung
- Guangdong Province Key Areas R&D Plan Project Fund
- Shenzhen Science and Technology Innovation Committee Technical Research Project
Zitieren
APA
Liu, M., Mu, T., Gu, J., Xu, M., & Chen, S. (2025). The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer. Cancer Reports. https://doi.org/10.1002/cnr2.70167
Vancouver
Liu M, Mu T, Gu J, Xu M, Chen S. The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer. Cancer Reports. 2025. doi:10.1002/cnr2.70167
BibTeX
@article{Liu2025,
author = {Liu, Ming and Mu, Tianhao and Gu, Jia and Xu, Mingyan and Chen, Shifu},
title = {The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70167}
}
EUVIMED